跳至主要内容
临床试验/JPRN-jRCT1080224091
JPRN-jRCT1080224091招募中Unknown

Investigation of the safety and efficacy of Budesonide ( Zentacort Capsules ) in patients with Crohn's disease

ZERIA Pharmaceutical Co., Ltd.0 个研究点目标入组 200 人开始时间: 2018年10月11日最近更新:
适应症

试验速览

阶段
Unknown
状态
招募中
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
All

入选标准

  • mild to moderate active Crohn's disease in patients

排除标准

  • 未提供

研究者

相似试验

进行中(未招募)
1 期
A 12-Week study to find out if the effect of Budesonide/Formoterol SPIROMAX® is at least the same as of SYMBICORT TURBOHALER® and is safe and effective to treat children, teenagers, and adults with asthma.Persistent AsthmaMedDRA version: 14.1Level: PTClassification code 10003553Term: AsthmaSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disorders
EUCTR2013-000081-11-BETeva Branded Pharmaceutical Products R&D, Inc.671
进行中(未招募)
不适用
A 12-Week study to find out if the effect of Budesonide/Formoterol SPIROMAX® is at least the same as of SYMBICORT TURBOHALER® and is safe and effective to treat children, teenagers, and adults with asthma.Persistent AsthmaMedDRA version: 14.1Level: PTClassification code 10003553Term: AsthmaSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disorders
EUCTR2013-000081-11-FITeva Branded Pharmaceutical Products R&D, Inc.600
已完成
3 期
A 12-Week Efficacy and Safety Evaluation of Budesonide/Formoterol SPIROMAX® 160/4.5 mcg Inhalation Powder Versus SYMBICORT® TURBOHALER® 200/6 mcg in Adult and Adolescent Patients with Persistent Asthma.chronical illness of the central nerve system10029305multiple sclerosis
NL-OMON38727TEVA Pharma12
进行中(未招募)
不适用
A 12-Week study to find out if the effect of Budesonide/Formoterol SPIROMAX® is at least the same as of SYMBICORT TURBOHALER® and is safe and effective to treat children, teenagers, and adults with asthma.Persistent AsthmaMedDRA version: 16.1Level: PTClassification code 10003553Term: AsthmaSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disorders
EUCTR2013-000081-11-DKTeva Branded Pharmaceutical Products R&D, Inc.600
进行中(未招募)
不适用
A 12-Week study to find out if the effect of Budesonide/Formoterol SPIROMAX® is at least the same as of SYMBICORT TURBOHALER® and is safe and effective to treat children, teenagers, and adults with asthma.
EUCTR2013-000081-11-ITTeva Branded Pharmaceutical Products R&D, Inc.600